#BEGIN_DRUGCARD DB03364

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H12N2O3S

# Chemical_IUPAC_Name:
(2R)-2-(carbamoylamino)-4-(methylsulfanyl)butanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Carbamyl-D-Methionine

# HET_ID:
CDT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H12N2O3S/c1-12-3-2-4(5(9)10)8-6(7)11/h4H,2-3H2,1H3,(H,9,10)(H3,7,8,11)/t4-/m1/s1

# InChI_Key:
InChIKey=DEWDMTSMCKXBNP-SCSAIBSYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3364

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
192.236

# Molecular_Weight_Mono:
192.05686295

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1UF5

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.88

# Predicted_LogS:
-1.2

# Predicted_Water_Solubility:
1.28e+01 g/l

# Primary_Accession_No:
DB03364

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
448878

# PubChem_Substance_ID:
46506719

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00877

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CSCC[C@@H](NC(N)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:11 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AB007368

# Drug_Target_1_GenBank_ID_Protein:
37896753

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>915 bp
ATGACACGTCAGATGATACTTGCAGTGGGACAACAAGGTCCGATCGCGCGCGCGGAGACA
CGCGAACAGGTCGTCGTTCGTCTTCTCGACATGCTGACGAAAGCCGCGAGCCGGGGCGCG
AATTTCATTGTCTTCCCCGAACTCGCGCTTACGACCTTCTTCCCGCGCTGGCATTTCACC
GACGAGGCCGAGCTCGATAGCTTCTATGAGACCGAAATGCCCGGCCCGGTGGTCCGTCCA
CTCTTTGAGAAGGCCGCGGAACTCGGGATCGGCTTCAATCTGGGCTACGCTGAACTCGTC
GTCGAAGGCGGCGTCAAGCGTCGCTTCAACACGTCCATTTTGGTGGATAAGTCAGGCAAG
ATCGTCGGCAAGTATCGTAAGATCCATTTGCCGGGTCACAAGGAGTACGAGGCCTACCGG
CCGTTCCAGCATCTTGAAAAGCGTTATTTCGAGCCGGGCGATCTCGGCTTCCCGGTCTAT
GACGTCGACGCCGCGAAAATGGGGATGTTCATCTGCAACGATCGCCGCTGGCCTGAAGCC
TGGCGGGTGATGGGCCTCAGGGGCGCCGAGATCATCTGCGGCGGCTACAACACGCCGACC
CACAATCCCCCTGTTCCCCAGCACGACCACCTGACGTCCTTCCACCATCTCCTATCGATG
CAGGCCGGGTCTTATCAGAACGGGGCCTGGTCCGCGGCCGCGGGCAAGGTGGGCATGGAG
GAGAACTGCATGCTGCTCGGCCACTCCTGCATCGTGGCGCCGACCGGGGAAATCGTCGCT
CTCACTACGACGCTGGAAGACGAGGTGATCACCGCCGCCGTCGATCTCGATCGCTGCCGG
GAACTGCGTGAACACATCTTCAACTTCAAGCAGCATCGTCAGCCCCAGCACTATGGTCTG
ATCGCGGAACTCTGA

# Drug_Target_1_General_Function:
Involved in hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds

# Drug_Target_1_General_References:
10903946	Nakai T, Hasegawa T, Yamashita E, Yamamoto M, Kumasaka T, Ueki T, Nanba H, Ikenaka Y, Takahashi S, Sato M, Tsukihara T: Crystal structure of N-carbamyl-D-amino acid amidohydrolase with a novel catalytic framework common to amidohydrolases. Structure. 2000 Jul 15;8(7):729-37.
9648217	Nanba H, Ikenaka Y, Yamada Y, Yajima K, Takano M, Takahashi S: Isolation of Agrobacterium sp. strain KNK712 that produces N-carbamyl-D-amino acid amidohydrolase, cloning of the gene for this enzyme, and properties of the enzyme. Biosci Biotechnol Biochem. 1998 May;62(5):875-81.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2423

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34286

# Drug_Target_1_Name:
N-carbamoyl-D-amino acid hydrolase

# Drug_Target_1_Number_of_Residues:
304

# Drug_Target_1_PDB_ID:
1ERZ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00795	CN_hydrolase

# Drug_Target_1_Protein_Sequence:
>N-carbamoyl-D-amino acid hydrolase
MTRQMILAVGQQGPIARAETREQVVVRLLDMLTKAASRGANFIVFPELALTTFFPRWHFT
DEAELDSFYETEMPGPVVRPLFEKAAELGIGFNLGYAELVVEGGVKRRFNTSILVDKSGK
IVGKYRKIHLPGHKEYEAYRPFQHLEKRYFEPGDLGFPVYDVDAAKMGMFICNDRRWPEA
WRVMGLRGAEIICGGYNTPTHNPPVPQHDHLTSFHHLLSMQAGSYQNGAWSAAAGKVGME
ENCMLLGHSCIVAPTGEIVALTTTLEDEVITAAVDLDRCRELREHIFNFKQHRQPQHYGL
IAEL

# Drug_Target_1_Reaction:
N-carbamoyl-D-amino acid + H2O = D-amino acid + NH3 + CO2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
The enzyme catalyzes the hydrolysis of N-carbamoyl-D- amino acids to the corresponding which are useful intermediates in the preparation of beta-lactam antibiotics. Industrial production of beta-lactam antibiotics is now being developed using this enzyme

# Drug_Target_1_SwissProt_ID:
P60327

# Drug_Target_1_SwissProt_Name:
DCAS_AGRSK

# Drug_Target_1_Synonyms:
D-N-alpha- carbamilase
EC 3.5.1.77

# Drug_Target_1_Theoretical_pI:
6.70

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03364
